1. Introduction {#sec-1}
===============

Colon cancer has become a major public health issue with 1,849,518 new cases in 2018. 10.2% of all cancer deaths in the same year were caused by this malign disease which brings it to the second rank in cancer related deaths \[1\]. Several factors (i.e. age, familial cancer syndromes, inflammatory bowel disease, dietary factors, hereditary polyposis conditions) affect the development of this malignancy \[2\]. Nowadays, the most accepted therapies are surgery, radiotherapy, and chemotherapy such as 5-fluorouracil and oxaliplatin \[3,4\]. However, all these procedures have their own difficulties, the adverse effects related to systemic chemotherapy are much restrictive due to their mortality. Since some of the natural products as chemotherapeutic agents indicate lower side effects on patients, they are promising anticancer agents and safer sources of cancer treatments. Moreover, such phytochemicals are also related with chemopreventive agents because of their eﬀiciency and low toxicity. Therefore, the scientists focus on evaluating phytochemicals with multitargeted potentials for eﬀective chemoprevention \[5\].

Terpenes (C10H16) illustrated enormous effectiveness as chemopreventive agent in the last years however the mechanism of action is not clear yet (a subclass of this family, terpenoids, has been characterized as monoterpenes, diterpenes, oligoterpenes, and polyterpenes). They involve roughly 25,000 chemical structures which are used in pharmaceutical industries \[6\]. Carvacrol is also a member of this family. The substance presents in various sources that are extensively tested with enormous biological activities \[7\]. Mediterraneans regularly consume this product with oregano spice that presents a lesser risk of colorectal cancer compared to the other local cuisines \[8\]. Nowadays, it is well-known that the carvacrol in this spice is the one reason that the substance has preventive properties. It basically protects mammalian cells against DNA strand breaks along with rosmarinic acid \[9,10\]. Moreover, several studies point out that carvacrol illustrates further anticancer effects such as genotoxic, cytotoxic, and proapoptotic activity to cancer cells, in a dose-dependent manner. Additionally, it has also an important preventive role in cell invasion by down regulating of matrix metalloprotease 2 and 9 expressions \[11\].

Tumor microenvironments involve various cell types and extracellular matrix substances in the niche of cancer such as soluble factors. The soluble factors which could be related to cell proliferation are granulocyte-macrophage colony-stimulating factor (GM-CSF), leptin, prolactin and soluble vascular endothelial growth factor receptor-2 (sVEGFR2) evaluated \[12\]. Prolactin may involve in the genetic and molecular mechanisms for regulating the proliferation and growth of neoplastic and normal epithelial cells in the gastrointestinal tract \[13\]. Moreover, leptin is crucial for colorectal cancer (CRC) growth in obese patients \[14\]. On the other hand, sVEGFR2 involves the extracellular domains of the receptor but lacks the tyrosine kinase domain \[15\]. GM-CSF has an important role in hematopoiesis and immune modulation. GM-CSF also stimulates the progression of immune-independent tumors by inducing tumor growth, metastasis, and promoting tumor microenvironments. Hence several studies suggest that this factor triggers some effects on tumor progression \[16\].

Since these soluble factors manage the tumor microenvironment and the behavior of cancer as mentioned previously, the present study investigates the changes in these soluble factors when HT-29 and HCT-116 colorectal adenocarcinoma cell lines are treated with carvacrol in a dose-dependent manner. We suggest that the results could lead us one step further to discover the mechanism of action of carvacrol through the soluble factors.

2. Materials and methods {#sec-2}
========================

2.1. Cell culture {#sec-2-1}
-----------------

Human colorectal carcinoma, HCT-116 (ATCC CCL-247) and HT-29 (ATCC HTB-38) cell lines were purchased from American Type Culture Collection (ATCC) (Rockville, CT, USA). They were cultured in McCoy's-5a modified medium (BiochromGbmH, Berlin, Germany) supplemented with 1% penicillin/streptomycin (BiochromGbmH, Berlin, Germany) and 10% fetal bovine serum (FBS, Cegrogen Biotech GmbH, Stadtallendorf, Germany). Cells were incubated at 37 °C in a humidified 5% CO2 incubator.

2.2. Cell viability {#sec-2-2}
-------------------

The antiproliferative effect of carvacrol (C7727, Sigma-Aldrich, St Louis, MO, USA) has been studied on HCT-116 and HT-29 colorectal adenocarcinoma cell lines. The cell lines were seeded in a triplicate in 96-well plate (10,000 cells per well). Cell viability was tested after 48 h of incubation with 25--200 µM carvacrol via xCELLigence real-time cell analysis instrument (ACEA Biosciences, Inc (ACEA), San Diego, California, USA).

2.3. Analysis of soluble factors via multiplexing assay {#sec-2-3}
-------------------------------------------------------

Colorectal adenocarcinoma cell lines, HCT-116, and HT-29 were treated with carvacrol at IC50 values individually. Both carvacrol treated and nontreated control groups were seeded into wells and run in triplicate. The fluorescent signal was measured by a CCD imager and the concentrations of the analytes were determined by MAGPIX xPONENT software. The results were normalized to total protein concentration estimated with Bradford assay.

2.4. Statistical analysis {#sec-2-4}
-------------------------

SPSS version 24.0 (IBM Corp., Armonk, NY, USA) was used for all analyses. Willcoxon signed ranks nonparametric test was used to determine the significance between the application of different doses of carvacrol on different cell lines individually and its control group. The data in the Figure are represented as the mean ± standard error of the mean. In the study, all tests were performed in triplicate. The level of statistical significance was set at P \< 0.05 .

3. Results {#sec-3}
==========

The current investigation draws attention to the carvacrol effect in proliferation and also points out its mechanism of action through the alterations in the level of soluble factors in colorectal cancer cell lines with different phenotypes. The methodology indicates the IC50 values for carvacrol and follows through the MAGPIX multiplexing assay to illuminate the changes in soluble factors in response to IC50 values of carvacrol on HCT-116 and HT-29 colorectal cancer cell lines.

3.1. The effect of carvacrol on cell proliferation of colorectal cancer cells {#sec-3-1}
-----------------------------------------------------------------------------

The in vitro proliferation activity doses of carvacrol on HCT-116 and HT-29 cell lines were measured by using the xCELLigence real-time cell analysis instrument. After 48 h of incubation with carvacrol, IC50 values were found as 92 µM for HCT-116 and 42 µM for HT-29 cell lines. The results are illustrated in Figure.

3.2. Carvacrol effect on soluble factors in colon cancer cell lines with different phenotypes {#sec-3-2}
---------------------------------------------------------------------------------------------

The soluble factors were analyzed to evaluate the cellular response leading to cytotoxicity in both cell lines and the difference between the response intensity to carvacrol. The measurements in samples were achieved by MAGPIX multiplexing assay. The Table which shows the normalized data illuminates that the secretion of several soluble factors related to growth and survival such as prolactin, leptin, and GM-CSF were increased in carvacrol treated HCT-116 while they were decreased in carvacrol treated HT-29 comparing to nontreated control groups. Prolactin, leptin, and GM-CSF concentrations were measured as 57.5, 9, and 82 pg/mL in HCT-116 and, 147, 17.74, and 104 pg/mL in HT-29 with no carvacrol concentration. These values raised in concentration to 117, 23, 105 pg/mL (P = 0.028 for all concentrations), in response to 92 µM and the IC50 value of carvacrol, respectively. However, they decreased to 53.49, 14.49, and 96 pg/mL concentrations (P = 0.028 for all concentrations) compared to the control concentrations in HT-29 treated with 42 µM of the phyto-compound. However, proliferative and survival factor TGF-α decreased in both cell lines, correlated with earlier proliferation assay. This factor was estimated as 67 pg/mL for HCT-116 and 106.2 pg/mL for HT-29. Both values diminished where the concentration for HCT-116 treated with 92 µM substance was 24 pg/mL (P = 0.028) and 26 pg/mL (P = 0.109) for HT-29 treated with 42 µM of carvacrol.

4. Discussion {#sec-4}
=============

The present study focused on the effect of carvacrol in proliferation and also illuminated its mechanism of action through the change in the level of soluble factors in colorectal cancer cell lines with different phenotypes. Both of these cell lines are treated with different doses of carvacrol which are 25 µM, 50 µM, 100 µM, 200 µM in xCELLigence real-time cell analysis instrument which measures the proliferation once per 15 min. The results signify that the proliferation levels of both cell lines decreased while the concentration level of carvacrol increased. A previous study points out that a carvacrol rich essential oil of origanumacutidens has also significant anti-proliferative effect against the HT-29 cell line. The most active concentration of this oil has been found as 100 μg/mL \[17\]. Moreover, similar to our results, Kai Fana et al. have studied the antiproliferative effect of carvacrol on HCT-116 and they detected the IC50 dose as 544.4 µM which is an even higher concentration comparing to our result \[11\]. Even though carvacrol has a significant antiproliferative effect on both of these cell lines in the dose-manner, our results indicate that it is more efficient against HT-29 since IC50 value of HCT-116 doubles the other line.

![The antiproliferation effect of carvacrol in colorectal cancer. Dose-dependent cytotoxicity activity of carvacrol on HT-29 (A). The HCT-116 cell line was incubated with increasing concentrations of curcumin (B). After 48 h of incubation at 37 °C and 5% CO2 the cell viability was measured by xCELLigence real-time cell analysis instrument.](turkjmedsci-50-271-fig001){#F1}

###### 

Statistically significant concentration levels of soluble factors in carvacrol treated samples compared to nontreated controls. All measurements were achieved by MAGPIX multiplexing assay. Red indicates a decrease whereas green illustrates an increase in concentrations compared to controls.
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  Groups    Soluble factors   Control (pg/mL)   Treated (pg/mL)   P- value   Evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  HT-29     GMCSF             104.0000          96.0000           0.028      decreased    FGF basic   55.4967   41.2467   0.028   decreased   GCSF        177.9967   116.7200   0.028   decreased   HGF    35.7567    27.9967    0.028   decreased   Leptin   17.7467   14.4967   0.028   decreased   Osteopontin   49.5000   61.6200   0.028   increased   PECAM1        72.7467   77.9967   0.028   increased   Prolactin   147.0000   53.4967   0.028   decreased   SCF         29.7467   46.2467    0.028   increased   sEGFR   57.9967   41.4967   0.028   decreased   sHER2neu   35.2467   22.9967   0.028   decreased   sIL6Ra   36.9967   12.4967   0.028   decreased   sTIE2   45.2467   44.0000   0.028   decreased   sVEGFR1   77.9967   10.4967   0.028   decreased   sVEGFR2   30.4967   14.9967   0.028   decreased   IL18   30.0000   19.4967   0.028   decreased   TGF   106.2467   25.9967   0.109   decreased   VEGFC   16.9967   40.9967   0.002   increased
  HCT-116   GMCSF             82.0000           105.0000          0.028      increased    IL8         30.0000   9.0000    0.028   decreased   FGF basic   22.4967    47.9967    0.028   increased   GCSF   116.2467   117.4967   0.028   increased   HGF      12.5000   15.0000   0.028   increased   Leptin        8.9967    23.4967   0.028   increased   Osteopontin   40.9933   53.5000   0.028   increased   PECAM1      16.4967    27.9967   0.028   increased   Prolactin   57.4967   117.0000   0.028   increased   SCF     44.7467   61.9967   0.028   increased   sHER2neu   28.2467   78.2467   0.028   increased   sIL6Ra   23.9967   27.4967   0.028   increased   sTIE2   39.2467   34.0000   0.028   decreased   sVEGFR1   72.2467   66.4967   0.028   decreased   sVEGFR2   10.0000   21.9967   0.028   increased   TGF    66.9967   23.9967   0.028   decreased                                                                                      
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The data of proliferation assay on the carvacrol effect point out that the phyto-compound has a significant role in both HCT-116 and HT-29 cell lines. However, the intensity of the cytotoxic responses is different since a more concentrated dose is required in HCT-116. Considering this result, the cellular response was evaluated by the means of secreted soluble factors via multiplexing assay (Table). The normalized data illuminate that the secretion of several soluble factors such as prolactin, leptin, and GM-CSF were increased in carvacrol treated HCT-116 while they were decreased in carvacrol treated HT-29 comparing to nontreated control groups. Considering this mitogenic effect, survival character was more abundant in HCT-116 whereas it reduced in HT-29 in response to the phyto-compound. Therefore, HCT-116 could be evaluated more resistant and aggressive in carvacrol treatment. Nevertheless, a significant decrease in proliferative and survival protein TGF-α and the increase in antigrowth factors VEGFR2 were correlated with the total cytotoxic effect in the final response.

The literature mostly confirms the results which we have obtained in the current study. The sVEGFR2 fragments, transfected to tumor cells, are secreted to the extracellular matrix and inhibit angiogenesis in vivo \[18\]. Another soluble factor increased in HCT-116, prolactin is actively involved in tumorigenesis in several cancers. The current research also points out that the prolactin level of HT-29 is dramatically lower compared to the control group. On the other hand, the level of this factor is enormously enhanced in the HCT-116 cell line. Moreover, the scientists investigated in improvement cures to control tumor growth via reducing the prolactin production \[19\]. The data introduced in the current study illuminates the levels of prolactin increased in HCT-116 as a result of favoring survival and proliferation, whereas it was decreased in HT-29. Therefore this growth-favored factor indicates that it is possible to enhance carvacrol treatment. In addition, the expression level of leptin was measured in lower levels in the HT-29 cell line compared to its control group. However, HCT-116 has an elevated level of this soluble factor. Since, previous reports suggest that leptin is overexpressed in various types of cancer cells and plays a role in the development and progression of a variety of malignancies including colon cancer. Our current study also reveals another reason why HCT-116 cell line was more resilient than HT-29 against this compound \[20,21\]. GM-CSF was another growth factor that decreased in HT-29 whereas it increased in HCT-116. In addition to the earlier studies indicating that neutralizing GM-CSF reduced the proliferation, angiogenesis, and colonic epithelial cells (CECs) in neoplasia, our data point out that this factor is also an accessory after the fact along with leptin and prolactin \[22\].

In conclusion, different colorectal cancer cell lines respond in distinct ways to this phytochemical compound. On one hand, the antiproliferative feature of carvacrol has been shown in both cell lines, on the other hand the HCT-116 response is more resistant to carvacrol treatment compared to HT-29 cell line. On the basis of present data, our results revealed that the alteration in levels of soluble factors in the HCT-116 cell line enhances the ability to proliferate and survive. Even though some of these factors slightly favored to tumor growth for HCT-116, carvacrol affects both cell lines as an antiproliferative agent. Therefore this study also suggests that some soluble factors could be drug targets to enhance the effectiveness of carvacrol.
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